牛牛AI助理已提取核心訊息
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of company stock on March 4, 2024. The transaction involved the disposal of 4,782 shares of common stock at a price of $11.1212 per share. Following the sale, Burnett's direct holdings in the company amount to 269,300 shares. The total value of the shares sold is approximately $53,181.58. This sale was executed in the open market and is part of the normal course of investment transactions.
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of company stock on March 4, 2024. The transaction involved the disposal of 4,782 shares of common stock at a price of $11.1212 per share. Following the sale, Burnett's direct holdings in the company amount to 269,300 shares. The total value of the shares sold is approximately $53,181.58. This sale was executed in the open market and is part of the normal course of investment transactions.
與Arcutis Biotherapeutics, Inc. [ARQT] 相關的帕特里克·伯內特於2024年3月4日完成了公司股票的出售。該交易涉及以每股11.1212美元的價格出售4,782股普通股。出售後，伯內特在該公司的直接持股量爲269,300股。出售的股票的總價值約爲53,181.58美元。此次出售是在公開市場上執行的，是正常投資交易過程的一部分。
與Arcutis Biotherapeutics, Inc. [ARQT] 相關的帕特里克·伯內特於2024年3月4日完成了公司股票的出售。該交易涉及以每股11.1212美元的價格出售4,782股普通股。出售後，伯內特在該公司的直接持股量爲269,300股。出售的股票的總價值約爲53,181.58美元。此次出售是在公開市場上執行的，是正常投資交易過程的一部分。
有用
沒用